MX156034A - Procidiemento para preparar el 3-ester-(ibencil-3-piperidil)-5-metil-ester, del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico - Google Patents
Procidiemento para preparar el 3-ester-(ibencil-3-piperidil)-5-metil-ester, del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilicoInfo
- Publication number
- MX156034A MX156034A MX199109A MX19910983A MX156034A MX 156034 A MX156034 A MX 156034A MX 199109 A MX199109 A MX 199109A MX 19910983 A MX19910983 A MX 19910983A MX 156034 A MX156034 A MX 156034A
- Authority
- MX
- Mexico
- Prior art keywords
- ester
- ibencil
- dihidropiridin
- dicarboxilico
- nitrofenil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57180616A JPS5970667A (ja) | 1982-10-15 | 1982-10-15 | １，４−ジヒドロピリジン誘導体 |
| JP58011719A JPS59137461A (ja) | 1983-01-27 | 1983-01-27 | １，４−ジヒドロピリジン誘導体 |
| JP58098899A JPS59225162A (ja) | 1983-06-03 | 1983-06-03 | １，４−ジヒドロピリジン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX156034A true MX156034A (es) | 1988-06-16 |
Family
ID=27279541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX199109A MX156034A (es) | 1982-10-15 | 1983-10-14 | Procidiemento para preparar el 3-ester-(ibencil-3-piperidil)-5-metil-ester, del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0106275B1 (es) |
| KR (1) | KR860001946B1 (es) |
| AU (1) | AU557175B2 (es) |
| CA (1) | CA1246078A (es) |
| DE (1) | DE3382204D1 (es) |
| ES (1) | ES526441A0 (es) |
| MX (1) | MX156034A (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1204336B (it) * | 1986-05-05 | 1989-03-01 | Luso Farmaco Inst | Processo per la preparazione di 2-(n-benzil-n-metilammino)-etil-metil1,4-diidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridin-dicarbossilato cloridrato |
| FR2671349B1 (fr) * | 1991-01-09 | 1993-04-23 | Lafon Labor | Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant. |
| AP2005003232A0 (en) | 2002-08-19 | 2005-03-31 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| ATE551059T1 (de) | 2005-10-26 | 2012-04-15 | Asahi Kasei Pharma Corp | Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie |
| EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| ES2382009T3 (es) | 2006-12-01 | 2012-06-04 | Bristol-Myers Squibb Company | Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares |
| CN102746215A (zh) * | 2011-04-18 | 2012-10-24 | 张兆勇 | 一种制备高纯度盐酸贝尼地平的方法 |
| CN102351784B (zh) * | 2011-10-20 | 2013-10-30 | 华夏药业集团有限公司 | 一种盐酸贝尼地平晶型及其应用 |
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
| CN103641774B (zh) * | 2013-11-26 | 2015-07-08 | 湖南方盛制药股份有限公司 | 盐酸贝尼地平的制备方法 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| CN104529872B (zh) * | 2014-12-10 | 2018-07-10 | 天津长源医药科技有限公司 | 一种盐酸贝尼地平中间体的合成方法 |
| WO2019053491A1 (en) | 2017-09-15 | 2019-03-21 | Deva Holding Anonim Sirketi | CRYSTALLINE BENIDIPINE HCL SOLID FORMS AND PROCESSES FOR PREPARING THE SAME |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
| CN112679416A (zh) * | 2020-12-31 | 2021-04-20 | 济南朗科医药技术有限公司 | 一种盐酸贝尼地平的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2218644C3 (de) * | 1972-04-18 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2659665A1 (de) * | 1976-12-30 | 1978-07-13 | Nattermann A & Cie | Neue 1,4-dihydropyridin-derivate |
| JPS55301A (en) * | 1978-02-14 | 1980-01-05 | Yamanouchi Pharmaceut Co Ltd | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation |
| JPS57171968A (en) * | 1981-04-17 | 1982-10-22 | Kyowa Hakko Kogyo Co Ltd | 1,4-dihydropyridine derivative |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
-
1983
- 1983-10-05 DE DE8383109968T patent/DE3382204D1/de not_active Expired - Lifetime
- 1983-10-05 AU AU19898/83A patent/AU557175B2/en not_active Expired
- 1983-10-05 EP EP19830109968 patent/EP0106275B1/en not_active Expired - Lifetime
- 1983-10-13 ES ES526441A patent/ES526441A0/es active Granted
- 1983-10-14 CA CA000438995A patent/CA1246078A/en not_active Expired
- 1983-10-14 MX MX199109A patent/MX156034A/es unknown
- 1983-10-15 KR KR1019830004886A patent/KR860001946B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3382204D1 (de) | 1991-04-18 |
| EP0106275A3 (en) | 1984-05-23 |
| EP0106275A2 (en) | 1984-04-25 |
| AU1989883A (en) | 1984-04-19 |
| EP0106275B1 (en) | 1991-03-13 |
| ES8600273A1 (es) | 1985-10-01 |
| ES526441A0 (es) | 1985-10-01 |
| AU557175B2 (en) | 1986-12-11 |
| CA1246078A (en) | 1988-12-06 |
| KR860001946B1 (ko) | 1986-11-01 |
| KR840006644A (ko) | 1984-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX156034A (es) | Procidiemento para preparar el 3-ester-(ibencil-3-piperidil)-5-metil-ester, del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico | |
| ES528577A0 (es) | Procedimiento para preparar acidos 4-fenil-1,3-dioxan-cis-5-ilalquenoicos | |
| ES519423A0 (es) | Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos. | |
| ES515426A0 (es) | Procedimiento para la obtencion de compuestos del acido 7 b-aminotiadiazolilacetilamino-3-amoniometil-3-cefem-4-carboxilico. | |
| AR226354A1 (es) | Procedimiento para preparar el complejo cis-isocitrato(1,2-diamino ciclohexano)plation | |
| ES520112A0 (es) | Un procedimiento para preparar amidas del acido 1-metil-5-p-toluoilpirrol-2-acetico. | |
| ES521337A0 (es) | Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico. | |
| ES523064A0 (es) | Procedimiento para preparar azetidinas. | |
| ES520323A0 (es) | Un procedimiento mejorado para preparar acido 2-ceto-l-gulonico. | |
| ES510330A0 (es) | Procedimiento para preparar etilenglicol. | |
| ES500032A0 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3,2,0) hept-2-en-2-carboxilico. | |
| ES525186A0 (es) | Procedimiento para preparar nuevas imidazo-(1,2-a)-pirimidinas | |
| ES520531A0 (es) | Procedimiento para preparar tioeteres. | |
| ES521813A0 (es) | Procedimiento para preparar alcohil-polisacaridos. | |
| ES501124A0 (es) | Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico. | |
| ES523664A0 (es) | Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico. | |
| ES530388A0 (es) | Procedimiento para preparar derivados del 2-azabiciclo-2.2.1-heptano. | |
| ES512387A0 (es) | "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico". | |
| ES518912A0 (es) | Un procedimiento para la preparacion de derivados del acido penicilanico. | |
| ES511759A0 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. | |
| ES521398A0 (es) | Procedimiento para preparar indolaminas sustituidas. | |
| ES524579A0 (es) | Procedimiento para preparar nitrometano. | |
| ES532108A0 (es) | Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos. | |
| ES521154A0 (es) | Procedimiento de preparacion del acido p-bifenilil-4-oxo-4-metil-2-butirico. | |
| ES495620A0 (es) | Procedimiento para preparar derivados del acido 2,7-fenan- trolina-9-carboxilico |